Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors

N. Houede, J. P. Delord, A. Awada, C. Lebbe, T. Lesimple, J. H. M. Schellens, S. Rottey, R. Kefford, O. von Richter, E. Raymond

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Article number600
Pages (from-to)184-184
Number of pages1
JournalEuropean Journal of Cancer
Publication statusPublished - Nov 2012
Externally publishedYes
Event24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Dublin, Ireland
Duration: 6 Nov 20129 Nov 2012

Cite this